Ginkgo Bioworks
DNA
DNA
169 hedge funds and large institutions have $437M invested in Ginkgo Bioworks in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 43 increasing their positions, 38 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 165 → 169 (+4)
7.88% less ownership
Funds ownership: 71.96% → 64.09% (-7.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
169
Holding in Top 10
4
Calls
$26M
Puts
$8.04M
Top Buyers
| 1 | +$5.36M | |
| 2 | +$2.81M | |
| 3 | +$2.8M | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$2.65M |
| 5 |
CAU
Caxton Associates (UK)
London,
|
+$1.89M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$8.73M | |
| 3 | -$5.63M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$5.56M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$5.14M |
